Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B

American Journal of Gastroenterology

Volumn 111, Issue 10, 2016, Pages 1410-1415

  Chang, Christine Y ^a,b   Aziz, Natali ^c   Poongkunran, Mugilan ^d   Javaid, Asad ^d   Trinh, Huy N ^e   Lau, Daryl ^d   Nguyen, Mindie H ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e San Jose Gastroenterology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; DNA; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; TELBIVUDINE; TENOFOVIR DISOPROXIL; ANTIVIRUS AGENT; VIRUS DNA;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; BILIRUBIN BLOOD LEVEL; CHRONIC HEPATITIS B; DECOMPENSATED LIVER CIRRHOSIS; ELASTOGRAPHY; FEMALE; HUMAN; ICD-9; LIVE BIRTH; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PARITY; PRIORITY JOURNAL; PUERPERIUM; RETROSPECTIVE STUDY; THIRD TRIMESTER PREGNANCY; UNITED STATES; BLOOD; GENETICS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PUERPERAL DISORDERS; STATISTICAL MODEL; VIRUS ACTIVATION;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PUERPERAL DISORDERS; RETROSPECTIVE STUDIES; VIRUS ACTIVATION;

EID: 84979497557     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2016.296     Document Type: Article

References (32)

1. World Health Organization. Hepatitis B. World Health Organization Fact Sheet 204 (Revised July 2015), http://www. who. int/mediacentre/factsheets/ fs204/en/, accessed Dec 2015.
2. Giles ML, Grace R, Tai A et al. Prevention of mother-to-child transmission of hepatitis B virus (HBV) during pregnancy and the puerperium: current standards of care. Aust N Z J Obstet Gynaecol 2013; 53: 231-5.
3. Canho R Del, Grosheide PM, Mazel JA et al. Ten-year neonatal hepatitis B vaccination program, the Netherlands, 1982-1992: protective effi cacy and long-term immunogenicity. Vaccine 1997; 15: 1624-30.
4. Patton H, Tran TT. Management of hepatitis B during pregnancy. Nat Rev Gastroenterol Hepatol 2014; 11: 402-9.
5. Xu WM, Cui YT, Wang L et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: A multicentre, rando mized, double-blind, placebo-controlled study. J Viral Hepat 2009; 16: 94-103.
6. Han G-R, Cao M-K, Zhao W et al. A prospective and open-label study for the effi cacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol 2011; 55: 1215-21.
7. Pan C, Lee H. Antiviral therapy for chronic hepatitis B in pregnancy. Semin Liver Dis 2013; 33: 138-46.
8. Dionne-Odom J, Tita ATN, Silverman NS. #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission. Am J Obstet Gynecol 2015; 214: 6-14.
9. Nguyen G, Garcia RT, Nguyen N et al. Clinical course of hepatitis B virus infection during pregnancy. Aliment Pharmacol Ther 2009; 29: 755-64.
10. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5: 266-71.
11. Giles ML, Visvanthan K, Lewin SR et al. Chronic hepatitis B infection and pregnancy. Obstet Gynecol Surv 2012; 67: 37-44.
12. Buchel E, Steenbergen W Van, Nevens F et al. Improvement of auto immune hepatitis during pregnancy followed by fl are-up aft er delivery. Am J Gastroenterol 2002; 97: 3160-5.
13. Paternoster DM, Santarossa C, Grella P et al. Viral load in HCV RNA-positive pregnant women. Am J Gastroenterol 2001; 96: 2751-4.
14. Chen JD, Chung JL, Kao JH et al. Post-partum acute exacerbation of chronic hepatitis in a hepatitis C-carrier mother. J Gastroenterol Hepatol 2001; 16: 705-8.
15. Lin HH, Chen PJ, Chen DS et al. Postpartum subsidence of hepatitis B viral replication in HBeAg-positive carrier mothers. J Med Virol 1989; 29: 1-6.
16. Dyson JK, Waller J, Turley A et al. Hepatitis B in pregnancy. Frontline Gastroenterol 2014; 5: 111-7.
17. Giles M, Visvanathan K, Lewin S et al. Clinical and virological predictors of hepatic fl ares in pregnant women with chronic hepatitis B. Gut 2015; 64: 1810-5.
18. Borg MJ Ter, Leemans WF, De Man RA et al. Exacerbation of chronic hepatitis B infection aft er delivery. J Viral Hepat 2008; 15: 37-41.
19. Tan H-H, Lui H-F, Chow W-C. Chronic hepatitis B virus (HBV) infection in pregnancy. Hepatol Int 2008; 2: 370-5.
20. Nguyen V, Tan PK, Greenup AJ et al. Anti-viral therapy for prevention of perinatal HBV transmission: Extending therapy beyond birth does not protect against post-partum fl are. Aliment Pharmacol Ther 2014; 39: 1225-34.
21. Singhal A, Kanagala R, Jalil S et al. Chronic HBV with pregnancy: Reactivation fl are causing fulminant hepatic failure. Ann Hepatol 2011; 10: 233-6.
22. Chen H-L, Lee C-N, Chang C-H et al. Effi cacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology 2015; 62: 375-86.
23. Zhang H, Pan CQ, Pang Q et al. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. Hepatology 2014; 60: 468-76.
24. Soderstrom A, Norkrans G, Lindh M. Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission. Scand J Infect Dis 2003; 35: 814-9.
25. Elefsiniotis I. Post-partum reactivation of chronic hepatitis B virus infection among hepatitis B e-antigen-negative women. World J Gastroenterol 2015; 21: 1261.
26. Samadi Kochaksaraei G, Castillo E, Osman M et al. Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region. J Viral Hepat 2015; 23: 15-22.
27. Lin HH, Wu WY, Kao JH et al. Hepatitis B post-partum e antigen clearance in hepatitis B carrier mothers: Correlation with viral characteristics. J Gastroenterol Hepatol 2006; 21: 605-9.
28. Han G-R, Jiang H-X, Yue X et al. Effi cacy and safety of telbivudine treatment: an open-label, prospective study in pregnant women for the prevention of perinatal transmission of hepatitis B virus infection. J Viral Hepat 2015; 22: 754-62.
29. Chang M-L, Liaw Y-F. Hepatitis B fl ares in chronic hepatitis B: pathogenesis, natural course, and management. J Hepatol 2014; 61: 1407-17.
30. Coffin CS, Lee SS. Editorial: anti-viral therapy for prevention of perinatal HBV transmission-extending therapy beyond birth and the risk of post-partum fl are. Aliment Pharmacol Ther 2014; 40: 115-6.
31. Terrault NA, Bzowej NH, Chang K-M et al. AASLD guidelines for treatment of chronic hepatitis B. Hepatology 2016; 63: 261-83.
32. Kelly E, Peters MG. Management of HBV in pregnancy. Curr Hepatol Reports 2015; 14: 145-52.